Meningococcal diseaseis a rare bacterial infection that can affect the brain, spinal cord, and bloodstream.
The disease can progress from mild, flu-like symptoms to death in a matter of hours.
Survivors are often left with long-term disabilities.
RLT_Images / Getty Images
While serious, meningococcal disease is rare.
Pfizer said the approval will allow providers to streamline the number of shots they give patients.
Who Can Get the New Meningococcal Vaccine?
Then, the preferred age for the MenB vaccine is between 16 and 18 years old.
Clinicians may recommend two doses of Penbraya for some people who are at high risk for meningococcal disease.
In those cases, the doses should be given at least six months apart.
The recommendations for vaccine timing may not be entirely set in stone.
Centers for Disease Control and Prevention.Meningococcal disease: surveillance.
Centers for Disease Control and Prevention.Meningococcal vaccination: what everyone should know.
